No Picture
Boston Cambridge Biotech Trending News

More drama ahead: Sarepta plans to file for accelerated Duchenne approval, with adcomm a ‘near certainty’

While Sarepta has three antisense oligonucleotide therapies approved — albeit not without controversy — for Duchenne muscular dystrophy, it has been working on a long-term treatment in the form of a gene therapy. After posting […]

No Picture
Los Angeles Biotech Trending News

Envista and dentalcorp Announce Strategic Implant Partnership

BREA, Calif., July 28, 2022 /PRNewswire/ — Envista Holdings Corporation (“Envista”) announced today an extension and expansion of their commercial partnership with dentalcorp Holdings Ltd., Canada’s largest DSO, network of dental practices. Since dentalcorp’s founding […]

No Picture
Los Angeles Biotech Trending News

The Former Director of the Center for Drug Evaluation and Research at FDA, Steven Galson, Joins Elephas as Independent Director

MADISON, Wis., July 28, 2022 /PRNewswire/ — Elephas Biosciences Corporation (Elephas), a company developing novel cancer diagnostic solutions, announced today the appointment of Steven Galson, M.D., M.P.H., as a member of the Board of Directors. […]

No Picture
News

Elevation Oncology dips its toes into ADCs, adding second drug to its bag. But is it pitting itself against Bristol Myers?

As interest grows in antibody drug conjugates, another small player is jumping into the space with sights set on an increasingly popular target. On Wednesday, Elevation Oncology licensed an ADC for gastric and pancreatic cancer […]